Article Type

ChemGreen Innovation

ChemGreen Innovation has developed and patented a diversified portfolio of clean-tech novel polymers and nano-materials focusing initially on antimicrobial, conductive, and magnetic properties.


Ayogo Health Inc., an emerging technology company that transforms the way consumers with chronic conditions engage with their own care, announced today a Series A investment of $2.5 million from a syndicate of investors

Oxalys Pharmaceuticals

Oxalys is developing drugs for neurodegenerative disease. We are a startup that spun out of MIT in 2011. Our first product will treat Huntington’s disease (HD)